Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
2.230
+0.080 (3.72%)
Sep 17, 2025, 12:52 PM EDT - Market open
Celularity Employees
Celularity had 123 employees as of December 31, 2024. The number of employees increased by 3 or 2.50% compared to the previous year.
Employees
123
Change (1Y)
3
Growth (1Y)
2.50%
Revenue / Employee
$362,520
Profits / Employee
-$598,935
Market Cap
59.52M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 123 | 3 | 2.50% |
Dec 31, 2023 | 120 | -105 | -46.67% |
Dec 31, 2022 | 225 | 0 | - |
Dec 31, 2021 | 225 | 63 | 38.89% |
Dec 31, 2020 | 162 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CELU News
- 14 days ago - Celularity Announces Filing of Form 10-Q Quarterly Reports for the First Quarter and the Second Quarter 2025, Confirmation of Nasdaq Listing Rule 5250(c)(1) Compliance - GlobeNewsWire
- 25 days ago - Celularity Receives Nasdaq Notice Regarding Form 10-Q - GlobeNewsWire
- 4 weeks ago - Celularity Completes Major Balance Sheet Restructuring, Retires All $41.6 Million in Senior Secured Debt - GlobeNewsWire
- 2 months ago - Celularity & Fountain Life Announce Partnership to Deliver Stem Cell Therapies Under New Florida Law - GlobeNewsWire
- 2 months ago - Celularity Hails New Florida Law Opening Patient Access to Stem Cell Therapies - GlobeNewsWire
- 3 months ago - Celularity Announces Chief Financial Officer Transition - GlobeNewsWire
- 3 months ago - Celularity Announces Publication Advancing Ocular Surface Reconstruction with Tri-Layer Amniotic Membrane Technology - GlobeNewsWire
- 4 months ago - Celularity Announces Full Year 2024 Operating and Financial Results - GlobeNewsWire